Scientists trace radioactive Drug's path in healthy volunteers
NCT ID NCT07471217
Summary
This is an early, small study to understand how the body processes a drug called Hydronidone, which is being developed for liver scarring from hepatitis B. Eight healthy Chinese men will receive a single dose containing a tiny, safe amount of radioactive tracer. Researchers will carefully measure how much of the drug is absorbed, broken down, and eliminated in urine and feces over several days.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS B-RELATED LIVER FIBROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Gaobo Hospital
Beijing, Beijing Municipality, 100000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.